Despite Katie Couric’s Advice, Doctors Say Ultrasound Breast Exams May Not Be Needed

Image
usf health primary care :: Article Creator The VA Adds A Veterans Health Clinic In An East Tampa Neighborhood A new satellite clinic run by the Department of Veteran Affairs in East Tampa is open for veterans to get primary care, mental health support and other services. It's part of a growing partnership between the Department of Veterans Affairs and Department of Defense. Officials from both agencies celebrated the Sabal Park clinic's grand opening during a ceremony on Monday. In the last year, the VA reported nearly 33,000 veterans in Florida signed up for health care. Many of them live in the Tampa Bay region, which has one of the largest veteran populations in the U.S. "It is always a challenge to have capacity meet that ever-growing demand, but it is our obligation to catch up to that demand as much as possible," Dr. Shereef Elnahal, VA Under Secretary for Health, said at the event. Stephanie Colombini / WUS

Experimental TB vaccine a ‘game changer’ that offers new hope - Business Day

The Bacille Calmette Guérin (BCG) vaccine, routinely given to babies around the world, was developed more than 90 years ago, and provides limited protection that wanes by adolescence. GSK’s candidate vaccine M72/AS01E was tested in 3,300 HIV negative adults in Kenya, SA and Zambia who had latent TB, and the results of the phase 2b trial were published in the New England Journal of Medicine this week.  

Participants were either given two doses of the vaccine or a placebo, and followed for three years to see if they developed pulmonary TB. Only 13 people who received the shots got TB, compared to 26 who did not.

“The trial is a game changer because it is the first time a TB vaccine candidate has been shown to offer protection to people who are already infected with the Mycobacterium tuberculosis bacillus. Those people, about two thirds of SA adults, are at risk of progression to TB disease,” said the study’s principal investigator Mark Hatherill, director of the SA Tuberculosis Vaccine Initiative.

GSK’s experimental vaccine contains TB proteins that trigger an immune response, but the mechanism is not yet fully understood, said Hatherill.

Further research was needed to determine whether the vaccine protected people who had not yet been infected with TB and those living with HIV, and to determine whether the protection was durable. Ideally a vaccine should confer protection for at least 10 years, he said.

“These questions must be asked and answered in a bigger confirmatory trial or trials, which will need a funding commitment from government and non-governmental stakeholders worldwide. These answers will be critical in getting the vaccine to a broad market,” he said.

In a separate development, French pharmaceutical manufacturer Sanofi announced on Thursday that it had slashed the price of its TB antibiotic rifapentine by two thirds, to a net ex-factory price of $15 for eligible countries in low and middle-income countries, including SA.



https://ift.tt/2N1VlgJ

Comments

Popular posts from this blog

Observership Program listings for international medical graduates

Vaccination Sites | Covid-19

Vaccination Sites | Covid-19